Auro Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve unaudited financial Results for the quarter ended September 30, 2026 and any other matter with the permission of Chair.

Auro Laboratories Limited 314,T.V.lndustrial Estate, S.K.Ahire Marg Worli,Mumbai - 400 030. India Tel.:+ 9122 6663 5456 Fax : + 91 22 6663 5460 Email : auro@aurolabs.com Web : www.aurolabs.com Reg.Off/ Mfg.Unit: K-56, M.I.D.C. Tarapur, Dist. Palghar, Maharashtra - 401506 CIN No. L33125MH1989PLC051910 Date: October 31, 2026 Listing Department, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai-400 001. Ref: Security Code No/lSIN: 530233/ INE292C01011 Dear Sir/Madam, Sub: Intimation of the Board Meeting as per Regulation 29(1)(a) of the SEBI {Listing Obligations and Disclosure Requirements) Regulations, 2015. We wish to inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on Friday, November 13, 2026, inter a1ia to: 1. To consider and approve Unaudited Financial Results of the Company for quarter and half year ended September 30, 2026 along with Limited Review Report thereon 2. Any other matter with the permission of the Chair. Further, in continuation to our earlier letter dated September 23, 2026, regarding closure of trading window in terms with Company's Code of Conduct for prevention of Insider Trading, we hereby inform that the trading window shall continue to remain dosed till 48 homs after the conclusion of the meeting of the Board for all Designated Persons (including their immediate relatives) of the Company. This intimation is also being uploaded on the Company's website and can be accessed at www. aurolabs.com We request you to take the above information on record and disseminate the same on your website. Thanking you, Yours faithfully, FOR TORIES LIMITED SIDDHARTHA DEORAH WHOLE TIME DIRECTOR [DIN: 00230796)